Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine

Adenovirus vectored vaccines are a highly effective strategy to induce cellular immune responses which are particularly effective against intracellular pathogens. Recombinant simian adenovirus vectors were developed to circumvent the limitations imposed by the use of human adenoviruses due to widesp...

書誌詳細
主要な著者:	Folegatti, P, Bellamy, D, Roberts, R, Powlson, J, Edwards, N, Mair, C, Bowyer, G, Poulton, I, Mitton, C, Green, N, Berrie, E, Lawrie, A, Hill, A, Ewer, K, Hermon-Taylor, J, Gilbert, S
フォーマット:	Journal article
出版事項:	MDPI 2019

類似資料

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
著者:: Pedro M. Folegatti, 等
出版事項: (2019-05-01)

Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
著者:: Zhang, C, 等
出版事項: (2023)

CMV-associated T cell and NK cell terminal differentiation does not impact immunogenicity of ChAdOx1 vaccination
著者:: Sharpe, HR, 等
出版事項: (2022)

Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
著者:: Cheng Zhang, 等
出版事項: (2023-06-01)

Stability of Chimpanzee Adenovirus Vectored Vaccines (ChAdOx1 and ChAdOx2) in Liquid and Lyophilised Formulations
著者:: Adam Berg, 等
出版事項: (2021-10-01)

CMV-associated T cell and NK cell terminal differentiation does not affect immunogenicity of ChAdOx1 vaccination
著者:: Hannah R. Sharpe, 等
出版事項: (2022-03-01)

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved influenza a antigens
著者:: Antrobus, R, 等
出版事項: (2014)

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens.
著者:: Antrobus, R, 等
出版事項: (2014)

Immunogenicity Differences of the ChAdOx1 nCoV-19 Vaccine According to Pre-Existing Adenovirus Immunity
著者:: Jinnam Kim, 等
出版事項: (2023-04-01)

Clinical assessment of ChAdOx1 vectored vaccines against emerging pathogens
著者:: Moreira Folegatti, P
出版事項: (2021)

A single dose of ChAdOx1 Chik vaccine induces neutralising antibodies against four chikungunya virus lineages in a phase 1 clinical trial
著者:: Folegatti, P, 等
出版事項: (2021)

Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector.
著者:: O'Hara, G, 等
出版事項: (2012)

Combined intranasal and intramuscular parainfluenza 5-, simian adenovirus ChAdOx1- and poxvirus MVA-vectored vaccines induce synergistically HIV-1-specific T cells in the mucosa
著者:: Ashley C. Beavis, 等
出版事項: (2023-07-01)

Safety and immunogenicity of adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies
著者:: Folegatti, P, 等
出版事項: (2021)

Safety and immunogenicity of ChAdOx1 MERS Vaccine Candidate in Healthy Middle Eastern Adults: a dose-escalation, open-label, non-randomised, phase 1b trial
著者:: Bosaeed, M, 等
出版事項: (2021)

Effect of Prior ChAdOx1 COVID-19 Immunisation on T-Cell Responses to ChAdOx1-HBV
著者:: Charlotte Davis, 等
出版事項: (2024-06-01)

A single dose of ChAdOx1 Chik vaccine induces neutralizing antibodies against four chikungunya virus lineages in a phase 1 clinical trial
著者:: Pedro M. Folegatti, 等
出版事項: (2021-07-01)

Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice
著者:: Dicks, M, 等
出版事項: (2015)

Design, Immunogenicity and Preclinical Efficacy of the ChAdOx1.COVconsv12 Pan-Sarbecovirus T-Cell Vaccine
著者:: Edmund G.-T. Wee, 等
出版事項: (2024-08-01)

Safety and Immunogenicity of Adenovirus and Poxvirus Vectored Vaccines against a Mycobacterium Avium Complex Subspecies
著者:: Pedro M. Folegatti, 等
出版事項: (2021-03-01)

Humoral immunogenicity and efficacy of a single dose of ChAdOx1 MERS vaccine candidate in dromedary camels
著者:: Alharbi, N, 等
出版事項: (2019)

Humoral Immunogenicity and Reactogenicity of the Standard ChAdOx1 nCoV-19 Vaccination in Taiwan
著者:: Jer-Hwa Chang, 等
出版事項: (2022-02-01)

Comparative effectiveness and safety of homologous two-dose ChAdOx1 versus heterologous vaccination with ChAdOx1 and BNT162b2
著者:: Hermosilla, E, 等
出版事項: (2022)

Safety and immunogenicity of a replication deficient simian adenoviral vectored chikungunya vaccine: A phase I, first-in-human, dose escalation trial
著者:: Folegatti, PM, 等
出版事項: (2019)

Association of Reactogenicity with Immunogenicity of the ChAdOx1 nCoV-19 Vaccine in Patients Undergoing Hemodialysis
著者:: Ting-Yun Lin, 等
出版事項: (2022-08-01)

HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV
著者:: Tamsin Cargill, 等
出版事項: (2023-11-01)

Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population
著者:: Nawamin Pinpathomrat, 等
出版事項: (2022-05-01)

Durability of ChAdOx1 nCov-19 vaccination in people living with HIV
著者:: Ogbe, A, 等
出版事項: (2022)

Comparative effectiveness and safety of homologous two-dose ChAdOx1 versus heterologous vaccination with ChAdOx1 and BNT162b2
著者:: Eduardo Hermosilla, 等
出版事項: (2022-03-01)

Immunogenicity and efficacy of Zika virus envelope domain III in DNA, protein, and ChAdOx1 adenoviral-vectored vaccines
著者:: López-Camacho, C, 等
出版事項: (2020)

Immunogenicity and Efficacy of Zika Virus Envelope Domain III in DNA, Protein, and ChAdOx1 Adenoviral-Vectored Vaccines
著者:: César López-Camacho, 等
出版事項: (2020-06-01)

Is the ChAdOx1 Vaccine Safe and Immunogenic as Prophylactic Measure Against the Lethal Human-Coronaviruses? A Systematic Review
著者:: Andréia Michelle Alves Cunha de Alcântar, 等
出版事項: (2023-07-01)

Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV
著者:: Ane Ogbe, 等
出版事項: (2022-04-01)

Impact of ChAdOx1 or DNA Prime Vaccination on Magnitude, Breadth, and Focus of MVA-Boosted Immunogen-Specific T Cell Responses
著者:: Alex Olvera, 等
出版事項: (2024-03-01)

Author Correction: Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population
著者:: Nawamin Pinpathomrat, 等
出版事項: (2022-09-01)

Safety and immunogenicity of CoronaVac and ChAdOx1 heterologous prime-boost vaccines in an overweight population in Chiang Mai, Thailand
著者:: Kriangkrai Chawansuntati, 等
出版事項: (2024-06-01)

Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured onthe AGE1.CR.pIX Avian Cell Line
著者:: Folegatti, P, 等
出版事項: (2019)

Simian adenoviruses as vaccine vectors
著者:: Morris, S, 等
出版事項: (2016)

Simian adenoviruses as vaccine vectors
著者:: Morris, S, 等
出版事項: (2016)

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
著者:: Folegatti, PM, 等
出版事項: (2020)